Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
Main Authors: | Sahith Kumar Shetty, Shyam Sundar Santhanakrishnan, Shubha Padurao, Pandareesh Mirazkar Dasharatharao |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2024-03-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c08112 |
Similar Items
-
Trabecular microarchitecture in cervical vertebrae
by: Manzanares Cespedes, M, et al.
Published: (2009) -
Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
by: Bala, Y, et al.
Published: (2014) -
Biomaterials / bioinks and extrusion bioprinting
by: X.B. Chen, et al.
Published: (2023-10-01) -
Are Artificial Intelligence-Assisted Three-Dimensional Histological Reconstructions Reliable for the Assessment of Trabecular Microarchitecture?
by: János Báskay, et al.
Published: (2024-02-01) -
Regional Variations in the Intra- and Intervertebral Trabecular Microarchitecture of the Osteoporotic Axial Skeleton with Reference to the Direction of Puncture
by: Guido Schröder, et al.
Published: (2024-02-01)